CardioGenics Holdings Inc. (OTCMKTS:CGNH – Get Free Report) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.00. CardioGenics shares last traded at $0.00, with a volume of 0 shares changing hands.
CardioGenics Stock Down 100.0%
About CardioGenics
CardioGenics Holdings Inc engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories.
Featured Stories
- Five stocks we like better than CardioGenics
- Stock Analyst Ratings and Canadian Analyst Ratings
- After Gold Blast Soars Past $4,000, BofA Eyes $5,000 in 2026
- Canada Bond Market Holiday: How to Invest and Trade
- Buyback Boom: 3 Companies Betting Big on Themselves
- Growth Stocks: What They Are, Examples and How to Invest
- Analysts Flock to Upgrade DELL After Big AI-Server Guidance Boost
Receive News & Ratings for CardioGenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CardioGenics and related companies with MarketBeat.com's FREE daily email newsletter.